Anxiety in youth at clinical high risk for psychosis
- PMID: 26456932
- PMCID: PMC4912451
- DOI: 10.1111/eip.12274
Anxiety in youth at clinical high risk for psychosis
Abstract
Aim: High rates of anxiety have been observed in youth at clinical high risk (CHR) of developing psychosis. In CHR, anxiety often co-occurs with depression, and there is inconsistent evidence on anxiety in relation to transition to psychosis. The aim of this study was to examine: (i) the prevalence of anxiety disorders in individuals at CHR; (ii) clinical differences between those with and without anxiety; and (iii) the association of baseline anxiety with later transition to psychosis.
Methods: The sample consisted of 765 CHR individuals and 280 healthy controls. CHR status was determined with the Structured Interview of Prodromal Syndromes, mood and anxiety diagnoses with the Structured Clinical Interview for DSM-IV Disorders, and severity of anxiety with the Social Interaction Anxiety Scale and Self-Rating Anxiety Scale.
Results: In the CHR sample, 51% met criteria for an anxiety disorder. CHR participants had significantly more anxiety diagnoses and severity than healthy controls. Anxiety was correlated to attenuated psychotic and negative symptoms in CHR and those with an anxiety disorder demonstrated more suspiciousness. CHR participants with obsessive-compulsive disorder (OCD) exhibited more severe symptomatology than those without OCD. An initial presentation of anxiety did not differ between those who did or did not transition to psychosis.
Conclusions: In this large sample of individuals at CHR, anxiety is common and associated with more severe attenuated psychotic symptoms. Treatment not only to prevent or delay transition to psychosis but also to address presenting concerns, such as anxiety, is warranted.
Keywords: anxiety; clinical high risk; obsessive-compulsive disorder; social phobia; suspiciousness.
© 2015 Wiley Publishing Asia Pty Ltd.
References
-
- Yung AR, McGorry PD. The initial prodrome in psychosis: descriptive and qualitative aspects. Aust N Z J Psychiatry. 1996 Oct;30(5):587–599. - PubMed
-
- Braga RJ, Reynolds GP, Siris SG. Anxiety comorbidity in schizophrenia. Psychiatry Res. 2013 Nov;210(1):1–7. - PubMed
-
- Hartley S, Barrowclough C, Haddock G. Anxiety and depression in psychosis: a systematic review of associations with positive psychotic symptoms. Acta Psychiatr Scand. 2013 Nov;128(5):327–346. - PubMed
-
- Huppert JD, Smith TE. Anxiety and schizophrenia: the interaction of subtypes of anxiety and psychotic symptoms. CNS Spectr. 2005 Sep;10(9):721–731. - PubMed
Publication types
MeSH terms
Grants and funding
- U01 MH082022/MH/NIMH NIH HHS/United States
- U01 MH081984/MH/NIMH NIH HHS/United States
- UL1 TR001863/TR/NCATS NIH HHS/United States
- U01 MH081902/MH/NIMH NIH HHS/United States
- P50 MH080272/MH/NIMH NIH HHS/United States
- U01 MH081988/MH/NIMH NIH HHS/United States
- P50 MH066286/MH/NIMH NIH HHS/United States
- U01 MH076989/MH/NIMH NIH HHS/United States
- K24 MH076191/MH/NIMH NIH HHS/United States
- R01 MH060720/MH/NIMH NIH HHS/United States
- U01 MH081928/MH/NIMH NIH HHS/United States
- U01 MH081857/MH/NIMH NIH HHS/United States
- U01 MH082004/MH/NIMH NIH HHS/United States
- U01 MH081944/MH/NIMH NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous